Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07517211 · ClinicalTrials.gov registry record
A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer, FAST-GO Study
A clinical trial, sponsored by Jonsson Comprehensive Cancer Center.
- Not yet
- Registry status
- 72
- Enrollment target
NCT07517211 is a clinical trial that has not yet begun recruiting, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 72 participants.
The verdict
NCT07517211 has not yet begun recruiting, sponsored by Jonsson Comprehensive Cancer Center.
- NOT YET RECRUITING
- Registry status
- 72 participants
- Enrollment target
Study Summary
This study evaluates how the treatment for gastroesophageal cancer affects physical function in patients who receive chemotherapy as part of their treatment for gastroesophageal cancer.
Interventions
- OTHER Non-Interventional Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2026-12-01 |
| Est. Completion | 2029-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07517211
The ClinicalTrials.gov registry entry for NCT07517211 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT07517211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07517211 about?
NCT07517211 is a clinical study titled "A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer, FAST-GO Study". This study evaluates how the treatment for gastroesophageal cancer affects physical function in patients who receive chemotherapy as part of their treatment for gastroesophageal cancer.
What is the current status of trial NCT07517211?
This trial is currently not yet recruiting. The enrollment target is 72 participants. The study started on 2026-12-01. Estimated completion is 2029-12-01.
What interventions are being tested in trial NCT07517211?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT07517211?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.